Ensuring treatment adherence with medications is vital in managing the acute symptoms of illness but can not completely cure the illness. This client was receiving atypical (new generation) anti psychotic medications: Aripriprazole 15 mg and Olanzapine 5 mg since 2008. The compliance with the medication and follow-up was ensured by the family as care provider. However, the persistent deterioration in the psychosocial functioning remained a concern for the psychiatrist and family throughout. Poor attention span, motivation, decision making, sense of pleasure, disability in self care and social relatedness were the major psychosocial concerns. These symptoms concur with the literature that indicates struggle with the management of these lingering deficits and disability though the compliance with the medication is maintained